Zydus Pharm Generic Fingolimod HCL Receives Tentative Approval in the U.S.
Pharmaceutical company Lupin on Thursday announced that it received approval from USFDA for efinaconazole topical solution.
Lupin Ltd's Generic Efinaconazole Receives Approval in the U.S.
Acrux Dds`s Generic Efinaconazole Receives Approval In US
Alembic Pharmaceuticals announced that its joint venture Aleor Dermaceuticals has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Efinaconazole Topical Solution, 10%. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Jublia Topical Solution, 10%, of Bausch Health Americas, Inc. (Bausch). Efinaconazole Topical Solution, 10% is indicated for the topical treatment of onychomycosis of the toenail(s) due to Trichophyton rubrum and Trichophyton mentagrophytes.
Perrigo Pharma`s Generic Efinaconazole Receives Approval in US
Global Efinaconazole Market Expected to Reach USD 875 Million by 2026
Teva Pharms` Generic Efinaconazole Receives Tentative Approval in US